Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech

Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech

Bharat Biotech International Ltd on Friday said its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in children and adolescents of 2-18 years age group in phase II/III study. The company conducted phase II/III, open-label, and multicentre study to evaluate the safety, reactogenicity and immunogenicity of Covaxin in healthy children and … Read more

COVID-19: Don’t let the guard down, caution experts

kerala coronavirus covid19 120

If caution is thrown to the wind, we could well be laying out an invitation for a second wave, which the country can ill afford. (PTI Photo/File) If there are reasons for India to take comfort in the declining new cases of the COVID-19 virus, there are equal reasons, if not more, for it to … Read more

COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert

vaccination 1

Almost all the major platforms to make the vaccines are being carried out in India by at least half a dozen leading Indian vaccine companies and many smaller companies. (AP photo) While the rich nations are facing shortages of COVID-19 vaccines despite their aggressive procurement plans and with the hope of getting the bulk of … Read more

Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax

CoWIN Govt starts contest for strengthening digital network platform for COVID 19 vaccine distribution 1

Covishield-maker Serum Institute applies to begin trials of its second COVID-19 vaccine Covovax: The announcement comes a day after Novovax Inc said that its Covid-19 vaccine Covovax was 89.3% effective in preventing Covid-19 in a trial conducting in the United Kingdom.(Representational image; Reuters/File Photo) Serum Institute to begin trial of second Covid-19 vaccine: Makers of … Read more

Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies vaccine roll out

vaccination 1

In the space for glass vials needed for the vaccines, companies have been expanding capacities and ramping up supplies. (AP image/Representational picture) Deliverance in the new year will come encased in glass vials stored in cooled boxes. As all hopes hinge on the first wave of COVID-19 vaccines, it is the vials that will carry … Read more

Covid-19 vaccination: Can’t deny chances of an adverse event, states told to be prepared, says health secretary

vaccination

India’s Case Fatality Rate (CFR) is 1.45 per cent, whereas globally it is 2.26 per cent, Bhushan avered, adding that India’s CFR is among the lowest in the world. (Representational image; AP photo) Union Health Secretary Rajesh Bhushan on Tuesday said that adverse events cannot be denied when the Covid-19 vaccination drive kicks off in … Read more

Does COVID-19 vaccine have similar immune response in old and young? Here’s what Moderna’s trials show

covid 19 vaccine 10

Moderna is now reporting interim data from the Phase 1 study, which includes new analysis from 20 additional people and details on how the vaccine performs in older people. (Representational image) Moderna Inc said on Wednesday that an analysis of the early-stage data of its experimental COVID-19 vaccine showed it induced immune responses in older … Read more

Reason behind rise in Covid cases? Coronavirus re-infections raise concerns about immunity

covid 19 symptoms

Some experts say it is likely that such cases are starting to emerge because of greater testing worldwide, rather than because the virus may be spreading differently. (Representational image) Two European patients are confirmed to have been re-infected with COVID-19, raising concerns about people’s immunity to the coronavirus as the world struggles to tame the … Read more

People not wearing masks, maintaining social distancing driving COVID-19 pandemic in India: ICMR DG

corona 1 4

The testing for the disease has been increased from 363 tests per million per day on August 1 to more than 600 tests per million per day at present, the ministry said with India having tested nearly 3.7 crore cumulative COVID-19 samples so far. ICMR Director General Balram Bhargava on Tuesday said “irresponsible” people not … Read more

Covid-19 vaccine: Bharat Biotech to finish screening of volunteers for trials by July-end

photo

New Delhi: Bharat Biotech will wrap up the screening of volunteers for the first phase of human clinical trials for its Covid-19 vaccine Covaxin by the end of July and select 375 of them to begin dosing by early August. The company developed Covaxin in collaboration with the Indian Council of Medical Research-National Institute of … Read more